PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, giving promising breakthroughs throughout different professional medical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, more trustworthy choice for the